About 50 percent of patients in cardiogenic shock do not survive, and account for about 90,000 heart attack patients a ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
June 18, 2018 — Heart defects are the most common type of birth defect, and can be caused by mutations in the gene CHD4 ...
June 18, 2018
June 15, 2018 — LivaNova PLC announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Memo ...
June 15, 2018
June 13, 2018 — Henry Ford Hospital is one of 17 U.S. trial sites using a catheter-based procedure approved in Europe to ...
June 13, 2018
June 13, 2018 — Medication management platform Medisafe released data showing that, on average, hypertensive patients ...
June 13, 2018
June 13, 2018 — Cardinal Health announced that its Incraft Abdominal Aortic Aneurysm (AAA) Stent Graft System has ...
June 13, 2018
June 7, 2018 — A new report from the U.S. Food and Drug Administration (FDA) discusses the continued quality, safety and ...
June 07, 2018
June 7, 2018 — The first clinical cases have been completed where the Emboliner Embolic Protection Catheter was used ...
June 07, 2018
June 6, 2018 — Maquet Datascope Corp. said it is recalling the CardioSave Hybrid Intra-aortic Balloon Pump (IABP) due to ...
June 06, 2018
June 5, 2018 — The future of cardiovascular care will be transformed by advances in artificial intelligence, digital ...
June 05, 2018
June 4, 2018 — The U.S. Food and Drug Administration said Medtronic initiated a Class 1 recall all 204,017 of its ...
June 04, 2018
June 1, 2018 – Use of the Abbott Portico transcatheter aortic valve replacement (TAVR) therapy was associated with ...
June 01, 2018
June 1, 2018 — The U.S. Food and Drug Administration (FDA) is issuing a proposed order to reclassify certain ...
June 01, 2018
May 31, 2018 – ReCor Medical announced that the RADIANCE-HTN SOLO study met its primary efficacy endpoint and ...
May 30, 2018
May 31, 2018 — The results from the Survival Improvement in Extensive Myocardial Infarction with PERsistent Ischemia ...
May 31, 2018